overig Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most 5 januari 2018FiercePharma
overig Look out, Teva: Mylan’s Copaxone copy has already captured serious share 5 januari 2018FiercePharma